- Full Year 2023 Altamira Therapeutics Ltd Earnings Call TranscriptApr 10, 2024$2 (+7.53%)Earnings
- Altamira Therapeutics Ltd to Host Investor & Business Update Call TranscriptDec 11, 2023
- Half Year 2023 Altamira Therapeutics Ltd Earnings Call TranscriptSep 12, 2023$6.39 (-6.03%)Earnings
- Q4 2022 Altamira Therapeutics Ltd Earnings Call TranscriptMay 16, 2023$17.99 (-3.87%)Earnings
- Altamira Therapeutics Ltd Business Update Conference Call TranscriptSep 14, 2022
- Q4 2021 Altamira Therapeutics Ltd Earnings Call TranscriptApr 12, 2022$456 (-31.33%)Earnings
- Altamira Therapeutics Ltd To Discuss Business Update Bentrio TM TranscriptSep 27, 2021
- Auris Medical Holding Ltd Acquires RNA Therapeutics Company - M&A Call TranscriptJun 03, 2021
- Q4 2020 Auris Medical Holding Ltd Earnings Call TranscriptApr 13, 2021$1720Earnings
- Half Year 2020 Auris Medical Holding Ltd Earnings Call TranscriptSep 17, 2020$327.36 (-1.68%)Earnings
- Q4 2019 Auris Medical Holding Ltd Earnings Call TranscriptApr 16, 2020$326.74 (-6.11%)Earnings
- Q2 2019 Auris Medical Holding Ltd Earnings Call TranscriptAug 15, 2019$1076 (-0.74%)Earnings
Q4 2019 Auris Medical Holding Ltd Earnings Call Transcript
Good morning, and welcome to Auris Medical's conference call. On today's call are Thomas Meyer, Auris Medical's Chairman and Chief Executive Officer; and Elmar Schaerli, Auris Medical's Chief Financial Officer, who will present the company this financial results for the second half and full year 2019 and provide with a business update.
The accompanying slides can be found on our website in the Investors section. Earlier today, Auris Medical issued a news release with the second half and full year 2019 financial results as well as a business update. The release is available on the company's website, aurismedical.com and filed with the SEC.
I would like now to hand the conference over to the Auris' Investor Relations to read the forward-looking statements.
Thank you, operator. During today's call, we'll be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements that address future operating, financial or business performance
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)